What move does the options market price into Vir Biotechnology's report?

Implied ±12.9%, either direction.

How often does Vir Biotechnology move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

VIRNasdaqBiological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc. (VIR) earnings date, market-implied expected move, and options open interest by expiry

11.31

+0.09 · +0.80%

Regular session09:30 ET

Open11.31Volume1.6MMkt cap$1.9BEPS-1.85

Day11.31 – 11.3150%52-wk4.82 – 12.1988%

VIR

Vir Biotechnology, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±12.9%implied · straddle

9.7812.66

spot 11.22exp Nov 20ATM strike 11ATM straddle 1.70IV 89%

Nov 3 close

Expected move

Inputs

Next report

Today

after close

est.Q3 FY26

Calendar

Next report

Last report

−3.79%

vs ±11.6% implied · ×0.33

shaded = implied · ▲▼ = realized

Aug 5 '26 · confirmed

Implied vs realized

Linked news

5dSNY · supplierSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance
6dALNY · supplierALNY trading halt (LUDP) · resumed 09:40 ET
9dXNCR · supplierXencor selects 400 mcg/kg IV as proposed Phase 3 dose after 45.5% cORR

News

Largest filed tie

13F top-10 QoQ

+17.03%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

237 managers

Top fund weight

0.47%

VIR weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Vir Biotechnology (VIR) is expected to report on Nov 4 after close (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±15.3%
avg realized: ±9.7%

Feb 26 '25Feb 26 '25confirmed±17.3%▼−11.85%×0.69

May 7 '25May 7 '25confirmed±13.3%▼−3.57%×0.27

Aug 6 '25Aug 6 '25confirmed±8.8%▼−14.37%×1.63

Q3 FY25Nov 5 '25confirmed±18.4%▼−5.19%×0.28

Jan 12 '26Jan 12 '26confirmed±12.2%▲+1.20%×0.10

Feb 23 '26Feb 23 '26confirmed±26.6%▲+27.73%×1.04

Q1 FY26May 6 '26confirmed±13.9%▼−9.91%×0.71

Q2 FY26Aug 5 '26confirmed±11.6%▼−3.79%×0.33

quarterimplied−30%0+30%realized×

Q2 FY26±11.6%▼−3.79%×0.33

Q1 FY26±13.9%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

0.39OI · 4 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

595+7%Nov 2016d1,544+12%

240%Dec 1844d0.08289+21%0.08

3190%Jan 1572d0.056,529−2%0.05

680%Apr 16163d0.041,695+5%0.04

ExpiryPutsCallsP/C

Nov 2016d595+7%1,544+12%0.39

Dec 1844d240%289+21%0.08

Jan 1572d3190%6,529−2%0.05

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±12.9%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Suppliers 1

XNCR±4.0%×0.31

Dashed = straddle · × = co-movement · max 500dMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

33.51%as filednet margin · revenue +19582.54% YoY

Revenue

$239M

Gross profit

$239M

100.00% margin

Operating income

$73M+155.53% QoQ

30.75% margin

Pre-tax income

$80M+163.94% QoQ

Net income

$80M+163.71% QoQ

33.51% margin

Operating expenses

$165M+25.12% QoQ

R&D $135M

SG&A $30M

Tax

$179,000+5.29% QoQ

Other income

$7M+0.40% QoQ

Revenue$239M

Gross profit

$239M

100.00% margin

Operating income

$73M+155.53%

30.75% margin

Pre-tax income

$80M+163.94%

Net income

$80M+163.71%

33.51% margin

Cost of revenue

Operating expenses

$165M+25.12%

R&D $135M

SG&A $30M

Other income$7M+0.40%

Tax$179,000+5.29%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 09:15 ET

Intraday

Event sensitivity

GDP ×1.22· ±3.6% vs ±3.0% · 19 releases

eventrelease day|move|up · n×base

GDPgross domestic product±3.6%10 of 19×1.22

CPROFcorporate profits±3.5%8 of 12×1.18

PPIproducer prices±3.2%5 of 10×1.10

PCEpersonal income & outlays±3.2%11 of 19×1.08

NFPjobs report±2.6%3 of 10×0.87

FOMCrate decision±2.5%9 of 24×0.83

CPIconsumer prices±2.4%4 of 10×0.83

Bar = avg |move| to ±4% · tick = ±3.0% avg day · ×base = |move| ÷ ±3.0% · min 6 releases

Earnings history

EPS 0.47 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 5 '26 · confirmed	0.47	—
Q1 FY26	May 6 '26 · confirmed	-0.85	—
Q3 FY25	Nov 5 '25 · confirmed	-1.17	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod